Published in Biochemistry on December 05, 2000
CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J Biol Chem (2010) 1.69
Type II membrane protein CD69 regulates the formation of resting T-helper memory. Proc Natl Acad Sci U S A (2012) 1.26
Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition. Immunity (2009) 1.22
CLEC2A: a novel, alternatively spliced and skin-associated member of the NKC-encoded AICL-CD69-LLT1 family. Immunogenetics (2007) 1.04
Characterization of alternatively spliced transcript variants of CLEC2D gene. J Biol Chem (2010) 1.02
Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex. Front Immunol (2013) 0.91
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia. Leuk Res (2009) 0.84
The high-resolution structure of the extracellular domain of human CD69 using a novel polymer. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.81
High allelic polymorphism, moderate sequence diversity and diversifying selection for B-NK but not B-lec, the pair of lectin-like receptor genes in the chicken MHC. Immunogenetics (2008) 0.80
Structure of NKp65 bound to its keratinocyte ligand reveals basis for genetically linked recognition in natural killer gene complex. Proc Natl Acad Sci U S A (2013) 0.80
Re-evaluation of binding properties of recombinant lymphocyte receptors NKR-P1A and CD69 to chemically synthesized glycans and peptides. Int J Mol Sci (2014) 0.77
Extended sequence of the turkey MHC B-locus and sequence variation in the highly polymorphic B-G loci. Immunogenetics (2011) 0.76
Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1). Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.75
Four crystal structures of human LLT1, a ligand of human NKR-P1, in varied glycosylation and oligomerization states. Acta Crystallogr D Biol Crystallogr (2015) 0.75
CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP. J Exp Med (2016) 0.75
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet (1977) 5.65
Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science (1986) 4.94
The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol (1993) 4.35
Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. Proc Natl Acad Sci U S A (1982) 3.73
Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens. Nature (1982) 3.34
Somatic cell hybridization of mouse myeloma cells. Cell (1976) 3.17
T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science (1994) 2.81
Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer. J Immunol (1983) 2.45
Crystal structure of the beta chain of a T cell antigen receptor. Science (1995) 2.37
The structural basis of T cell activation by superantigens. Annu Rev Immunol (1999) 2.34
Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 2.22
Bound water molecules and conformational stabilization help mediate an antigen-antibody association. Proc Natl Acad Sci U S A (1994) 2.18
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity (2000) 2.13
Structure and function of the T-cell receptor: insights from X-ray crystallography. Immunol Today (1996) 2.02
"Exon-shuffling" maps control of antibody- and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A beta. Proc Natl Acad Sci U S A (1985) 1.93
Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med (1994) 1.74
Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer. Proc Natl Acad Sci U S A (1983) 1.74
Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol (2000) 1.71
Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature (1999) 1.69
The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure. Science (1986) 1.68
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68
Hybrid H-2 histocompatibility gene products assign domains recognized by alloreactive T cells. Proc Natl Acad Sci U S A (1983) 1.67
Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes. J Exp Med (1984) 1.65
Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. J Immunol (1995) 1.58
H-2-like genes in the Tla region of mouse chromosome 17. Nature (1982) 1.54
Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution. J Biol Chem (1991) 1.54
T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4. Nature (1985) 1.53
Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med (1992) 1.46
Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex. J Exp Med (1992) 1.43
Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J Immunol (1995) 1.42
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J Mol Biol (1996) 1.41
A T cell receptor transgenic model of severe, spontaneous organ-specific autoimmunity. Eur J Immunol (2001) 1.41
A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Biochemistry (1998) 1.39
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med (1998) 1.39
Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. J Exp Med (1989) 1.35
Three-dimensional structure of an antigen-antibody complex at 6 A resolution. Nature (1985) 1.34
Molecular basis of antigen mimicry by an anti-idiotope. Nature (1995) 1.32
Lysine 271 in the transmembrane domain of the T-cell antigen receptor beta chain is necessary for its assembly with the CD3 complex but not for alpha/beta dimerization. J Biol Chem (1990) 1.29
H-2 hemizygous mutants from a heterozygous cell line: role of mitotic recombination. EMBO J (1983) 1.28
Regulation of immunoglobulin expression in mouse myeloma cells. Cold Spring Harb Symp Quant Biol (1977) 1.28
Minimal requirements for peptide mediated activation of CD8+ CTL. Mol Immunol (1994) 1.28
Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J Immunol (1994) 1.25
Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules. Nature (1991) 1.22
Functional expression of a transfected murine class II MHC gene. Nature (1984) 1.22
Crystal structure of the V alpha domain of a T cell antigen receptor. Science (1995) 1.21
Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population. Biochemistry (1995) 1.20
Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur J Immunol (1999) 1.20
A mutational analysis of the binding of two different proteins to the same antibody. Biochemistry (1996) 1.18
A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity (1995) 1.17
Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining. Int Immunol (2001) 1.17
Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J Mol Biol (2000) 1.17
Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med (1995) 1.16
The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. Proc Natl Acad Sci U S A (1996) 1.15
Thermodynamics of antigen-antibody binding using specific anti-lysozyme antibodies. Eur J Biochem (1995) 1.14
Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface. Biochemistry (2000) 1.14
The structure of the T cell antigen receptor. Annu Rev Immunol (1996) 1.14
Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity. J Biol Chem (1993) 1.13
H-2Dd exploits a four residue peptide binding motif. J Exp Med (1993) 1.13
Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell (1989) 1.12
High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J Mol Biol (2001) 1.10
Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3. Immunol Rev (1998) 1.10
Solvent rearrangement in an antigen-antibody interface introduced by site-directed mutagenesis of the antibody combining site. J Mol Biol (1994) 1.08
The structural basis of antigen-antibody recognition. Annu Rev Biophys Biophys Chem (1987) 1.08
Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions. Structure (2000) 1.08
Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin. Proc Natl Acad Sci U S A (1992) 1.07
Control of autoimmunity by regulatory T cells. Adv Exp Med Biol (2001) 1.07
Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells. J Immunol (2001) 1.06
Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants. J Immunol (1986) 1.06
Independent and synergistic effects of disulfide bond formation, beta 2-microglobulin, and peptides on class I MHC folding and assembly in an in vitro translation system. J Immunol (1992) 1.05
Role of the T cell receptor ligand affinity in T cell activation by bacterial superantigens. J Biol Chem (2001) 1.05
Analysis of binding interactions in an idiotope-antiidiotope protein-protein complex by double mutant cycles. Biochemistry (1997) 1.04
Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes. Immunity (1999) 1.04
Linkage of beta 2-microglobulin and ly-m11 by molecular cloning and DNA-mediated gene transfer. Proc Natl Acad Sci U S A (1983) 1.04
Structure of the Vdelta domain of a human gammadelta T-cell antigen receptor. Nature (1998) 1.04
MHC class I molecules, structure and function. Rev Immunogenet (1999) 1.03
Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,). Biochemistry (2000) 1.03
Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site. Immunity (1999) 1.02
Measuring interactions of MHC class I molecules using surface plasmon resonance. J Immunol Methods (1995) 1.01
Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. J Mol Biol (1998) 1.01
The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. J Biol Chem (1994) 1.00
Alternative protein products with different carboxyl termini from a single class I gene, H-2Kb. Proc Natl Acad Sci U S A (1986) 1.00
A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor. Cell Immunol (2001) 0.99
Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression. J Immunol (1992) 0.99
Serologic and T cell recognition of truncated transplantation antigens encoded by in vitro deleted class I major histocompatibility genes. J Immunol (1986) 0.97
An allosteric mechanism controls antigen presentation by the H-2K(b) complex. Biochemistry (1999) 0.96
A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes. J Immunol (1997) 0.96
Preliminary crystallographic study of the complex between the Fab fragment of a monoclonal anti-lysozyme antibody and its antigen. J Mol Biol (1983) 0.96
Activating CTL precursors to reveal CTL function without skewing the repertoire by in vitro expansion. Eur J Immunol (2001) 0.95
The effect of water activity on the association constant and the enthalpy of reaction between lysozyme and the specific antibodies D1.3 and D44.1. J Mol Recognit (1996) 0.95
TCR avidity: it's not how strong you make it, it's how you make it strong. Nat Immunol (2001) 0.95
Alternative processing of H-2Dd pre-mRNAs results in membrane expression of differentially phosphorylated protein products. EMBO J (1986) 0.95
A family of murine NK cell receptors specific for target cell MHC class I molecules. Semin Immunol (1995) 0.95
Imperfect interfaces. Nat Struct Biol (1998) 0.94